The olanzapine long-acting injectable (TEV-'749) is designed to deliver the efficacy of olanzapine in a subcutaneous formulation 1 administered every four weeks. If approved, TEV-'749 could help fill ...

Interact, the employee experience platform trusted by leading enterprises including Levi's, Domino's, and Teva Pharmaceuticals, is marking one of its most significant chapters at a moment when ...

ZIM names Chen Lichtenstein CEO effective July 1, 2026 after Eli Glickman resigns; see shareholder approval details and ...

Medincell (Euronext Paris: MEDCL), a commercial- and clinical-stage biopharmaceutical licensing company developing ...

A landmark quarter brings a new visual identity, agentic AI capabilities, and recognition across the category's leading analyst reportsMANCHESTER, United Kingdom and NEW YORK, May 27, 2026 (GLOBE NEWS ...

A compound named “substance God help me” by its longtime champion could benefit from RFK Jr.'s favorable views on using ...

Head of the world's largest generic drugmaker unveils program to address the growing need for care as more than 2 million ...

Today, Sikiric and his team describe BPC-157 as an all-purpose healing compound. Laboratory experiments with animals and cell cultures, they write, suggest the peptide may treat everything from muscle ...

Four years after Rooney cited BDS in declining a different Israeli publisher, she speaks with activist Samir Eskanda about the artist’s role in the boycott movement ...

Key Points Interested in Veeva Systems Inc.? Here are five stocks we like better. Veeva Systems said it had a strong first ...